Protagenic Therapeutics Inc (PTIX)
1.26
+0.01
(+0.80%)
USD |
NASDAQ |
May 07, 15:40
Protagenic Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | -36.69% |
| June 30, 2011 | -98.13% |
| March 31, 2011 | -49.81% |
| December 31, 2010 | -104.2% |
| September 30, 2010 | -39.62% |
| June 30, 2010 | -41.54% |
| March 31, 2010 | -28.16% |
| December 31, 2009 | -175.3% |
| September 30, 2009 | -16.04% |
| June 30, 2009 | -11.45% |
| March 31, 2009 | -5.04% |
| December 31, 2008 | -509.5% |
| September 30, 2008 | -0.02% |
| June 30, 2008 | 3.39% |
| March 31, 2008 | -0.93% |
| December 31, 2007 | -6.74% |
| September 30, 2007 | -18.57% |
| June 30, 2007 | -12.87% |
| March 31, 2007 | -6.59% |
| October 31, 2006 | |
| July 31, 2006 | |
| April 30, 2006 | -7.83% |
| January 31, 2006 | |
| October 31, 2005 | |
| April 30, 2003 | -6.98% |
| Date | Value |
|---|---|
| January 31, 2003 | -18.72% |
| October 31, 2002 | -14.32% |
| July 31, 2002 | -10.44% |
| April 30, 2002 | -3.78% |
| January 31, 2002 | -5.94% |
| October 31, 2001 | 2.76% |
| July 31, 2001 | -5.54% |
| April 30, 2001 | 0.40% |
| January 31, 2001 | 1.99% |
| October 31, 2000 | 6.24% |
| July 31, 2000 | 4.89% |
| April 30, 2000 | 4.22% |
| January 31, 2000 | 3.77% |
| October 31, 1999 | 9.55% |
| July 31, 1999 | -16.64% |
| April 30, 1999 | -4.78% |
| January 31, 1999 | |
| October 31, 1998 | 6.25% |
| July 31, 1998 | 1.23% |
| April 30, 1998 | 6.67% |
| January 31, 1998 | |
| October 31, 1997 | 7.50% |
| July 31, 1997 | -7.41% |
| April 30, 1997 | |
| January 31, 1997 | -20.69% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | -91.29% |
| Eyenovia Inc | -307.7K% |
| Palisade Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |